These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
666 related articles for article (PubMed ID: 8609163)
21. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition. Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177 [TBL] [Abstract][Full Text] [Related]
22. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain. Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595 [TBL] [Abstract][Full Text] [Related]
23. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Riewald M; Ruf W Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7742-7. PubMed ID: 11438726 [TBL] [Abstract][Full Text] [Related]
24. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor. Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255 [TBL] [Abstract][Full Text] [Related]
25. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1. Ahamed J; Belting M; Ruf W Blood; 2005 Mar; 105(6):2384-91. PubMed ID: 15550483 [TBL] [Abstract][Full Text] [Related]
28. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity. Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987 [TBL] [Abstract][Full Text] [Related]
29. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X. Doñate F; Kelly CR; Ruf W; Edgington TS Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793 [TBL] [Abstract][Full Text] [Related]
30. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin. Sandset PM; Abildgaard U Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748 [TBL] [Abstract][Full Text] [Related]
31. Tissue factor pathway inhibitor: a possible mechanism of action. Panteleev MA; Zarnitsina VI; Ataullakhanov FI Eur J Biochem; 2002 Apr; 269(8):2016-31. PubMed ID: 11985578 [TBL] [Abstract][Full Text] [Related]
32. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. Zhang E; St Charles R; Tulinsky A J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787 [TBL] [Abstract][Full Text] [Related]
33. Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength. Thomassen S; Mastenbroek TG; Swieringa F; Winckers K; Feijge MAH; Schrijver R; Cosemans JMEM; Maroney SA; Mast AE; Hackeng TM; Heemskerk JWM Thromb Haemost; 2018 Mar; 118(3):502-513. PubMed ID: 29452445 [TBL] [Abstract][Full Text] [Related]
34. Regulation of tissue factor-factor VIIa expression on cell surfaces: a role for tissue factor-factor VIIa endocytosis. Rao LV; Pendurthi UR Mol Cell Biochem; 2003 Nov; 253(1-2):131-40. PubMed ID: 14619963 [TBL] [Abstract][Full Text] [Related]